General
Preferred name
DOXERCALCIFEROL
Synonyms
Doxercalciferol-D3 ()
1¦Á-hydroxyvitamin D2 ()
1.alpha.-Hydroxyvitamin D2 ()
1-.ALPHA.-HYDROXYERGOCALCIFEROL ()
1-ALPHA-HYDROXYERGOCALCIFEROL ()
1-HYDROXYERGOCALCIFEROL ()
1.ALPHA.-HYDROXYERGOCALCIFEROL ()
GZ427397 ()
Hectorol ()
TSA-840 ()
P&D ID
PD012246
CAS
54573-75-0
Tags
available
drug
prodrug
Approved by
FDA
First approval
1999
Drug indication
Chronic kidney disease
psoriasis
Drug Status
approved
Max Phase
4.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Doxercalciferol is a synthetic analogue of vitamin D2 (ergocalciferol). (GtoPdb)
PRICE 110
DESCRIPTION Doxercalciferol (TSA 840) is a synthetic vitamin D2 analog, suppressing parathyroid synthesis and secretion, used to treat secondary hyperparathyroidism and metabolic bone disease.
Compound Sets
20
Axon Medchem Screening Library
ChEMBL Approved Drugs
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Concise Guide to Pharmacology 2025/26
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
EUbOPEN Chemogenomics Library
Guide to Pharmacology
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NPC Screening Collection
Other bioactive compounds
External IDs
60
Properties
(calculated by RDKit )
Molecular Weight
412.33
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
2
Rotatable Bonds
5
Ring Count
3
Aromatic Ring Count
0
cLogP
6.61
TPSA
40.46
Fraction CSP3
0.71
Chiral centers
7.0
Largest ring
6.0
QED
0.5
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
VD/VDR
VDR agonist
Environmental Pollutants
Pathway
Vitamin D Related
Vitamin D Related/Nuclear Receptor
Recommended Cell Concentration
1 uM
Source data